p65 antibody (Nuclear Factor-KB P65)

Details for Product anti-NFkBP65 Antibody No. ABIN2475874
Antigen
  • C-Rel
  • NFKB3
  • p65
  • NFkB
  • c-rel
  • zgc:100833
  • REL proto-oncogene, NF-kB subunit
  • RELA proto-oncogene, NF-kB subunit
  • v-rel reticuloendotheliosis viral oncogene homolog A (avian)
  • v-rel avian reticuloendotheliosis viral oncogene homolog
  • REL
  • RELA
  • Rela
  • Rel
  • rel
Reactivity
Human, Mouse (Murine), Rat (Rattus)
1134
711
584
77
69
47
22
19
16
12
8
8
5
3
1
1
1
Host
Rabbit
1067
81
10
2
1
Clonality
Polyclonal
Conjugate
This p65 antibody is un-conjugated
45
28
26
26
26
26
26
26
20
13
12
11
8
8
8
8
8
3
2
2
Application
Gel Shift (GS), Immunofluorescence (IF), Immunoprecipitation (IP), ELISA, Western Blotting (WB)
849
449
410
204
182
154
106
59
41
33
27
19
16
13
12
9
4
4
3
1
Options
Isotype IgG
Cross-Reactivity Mouse (Murine), Rat (Rattus)
Characteristics Serum
Plasmids, Primers & others Plasmids, Primers & others p65 products on genomics-online (e.g. as negative or positive controls)
Antigen
Alternative Name NFkB p65 (NFkBP65 Antibody Abstract)
Gene ID 5970
UniProt Q04206
Pathways NF-kappaB Signaling, RTK Signaling, TCR Signaling, TLR Signaling, Fc-epsilon Receptor Signaling Pathway, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Hepatitis C, Toll-Like Receptors Cascades
Application Notes Optimal working dilution should be determined by the investigator.
Restrictions For Research Use only
Format Liquid
Product cited in: Parmentier, Hirani, Rahman, Donaldson, MacNee, Antonicelli: "Regulation of lipopolysaccharide-mediated interleukin-1beta release by N-acetylcysteine in THP-1 cells." in: The European respiratory journal, Vol. 16, Issue 5, pp. 933-9, 2001 (PubMed).

Cruz, Duarte, Gonçalo, Carvalho, Lopes: "Involvement of JAK2 and MAPK on type II nitric oxide synthase expression in skin-derived dendritic cells." in: The American journal of physiology, Vol. 277, Issue 6 Pt 1, pp. C1050-7, 2000 (PubMed).

Gründker, Schulz, Günthert, Emons: "Luteinizing hormone-releasing hormone induces nuclear factor kappaB-activation and inhibits apoptosis in ovarian cancer cells." in: The Journal of clinical endocrinology and metabolism, Vol. 85, Issue 10, pp. 3815-20, 2000 (PubMed).

Did you look for something else?